Plunkett Research Online: Ligand Pharmaceuticals Incorporated

LIGAND PHARMACEUTICALS INCORPORATED (LGND:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The firm offers research technologies such as nuclear receptor assays, high throughput computer screening, formulati.....



Ligand Pharmaceuticals Incorporated
Ticker: LGND
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 858 550-7500
Fax: 850 550-1826
Address: 3911 Sorrento Valley Boulevard
Suite 110
San Diego, CA 92121 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Diversified
Small-Molecule Drugs
ContactsDescription
John HigginsCEO/Director
Matthew KorenbergCFO/Executive VP, Divisional
See More
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The firm offers research technologies such as nuclear receptor assays, high throughput computer screening, formulati.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Promacta
Kyprolis
Evomela
Baxdela
Captisol
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: